A new study has identified a specific class of pharmaceutical drugs that could be effective in treating babies vulnerable to Sudden Infant Death syndrome (SIDS), because their mothers smoked during pregnancy.
A new study has identified a specific class of pharmaceutical drugs that could be effective in treating babies vulnerable to Sudden Infant Death syndrome (SIDS), because their mothers smoked during pregnancy.